RGLS:
Analysis & Opinions
-
November 07, 2012
Isis Pharmaceuticals Inc. (ISIS) reported a adjusted net loss of 33 cents per share in the third quarter of 2012, ...
-
October 12, 2012
Isis Pharmaceuticals, Inc. (ISIS) recently announced that it has invested $3 million in biopharma company Regulus ...
